Supernus Pharmaceuticals, Inc. (SUPN)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.52B
Last updated: Nov 17, 2026 at 4:33 PM ET
Supernus Pharmaceuticals, Inc. (SUPN) Stock Chart
Supernus Pharmaceuticals (SUPN) has a latest price of $29.04 on Nov 17, 2026, 12.6% below its 52-week high of $33.22. Its price fell 35.5% over the past 12 months. The month-end price fell 64.3% over the 10 years through Oct 2026, a compound annual decline of 9.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $299.25 in Jun 2018 and its lowest $23.85 in Oct 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SUPN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SUPN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.1%, and over 6 months it fell 39.0%. The month-end price rose 48.3% over the 3 years through Oct 2026, a compound annual rate of 14.0%.
| Period | Change |
|---|---|
| 1 month | +10.5% |
| 3 months | -4.1% |
| 6 months | -39.0% |
| 12 months | -35.5% |
| 12 months, with dividends | -17.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +48.3% | +14.0% |
| 5 years | -76.3% | -25.0% |
| 10 years | -64.3% | -9.8% |
Price by Year
Its best calendar year was 2017, when the price rose 57.8%, and its weakest was 2022, when it fell 75.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $35.37 | -28.8% |
| 2025 | $49.70 | +37.4% |
| 2024 | $36.16 | +24.9% |
| 2023 | $28.94 | -18.9% |
| 2022 | $35.67 | -75.5% |
| 2021 | $145.80 | +15.9% |
| 2020 | $125.80 | +6.1% |
| 2019 | $118.60 | -28.6% |
| 2018 | $166.10 | -16.6% |
| 2017 | $199.25 | +57.8% |
Trading Range
The price is 5.5% above its 50-day average of $27.54 and 24.6% below its 200-day average of $38.50.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $29.04 | |
| 52-week high | $33.22 | -12.6% |
| 52-week low | $21.48 | +35.2% |
| 50-day average | $27.54 | +5.5% |
| 200-day average | $38.50 | -24.6% |
Price Risk
Over 3 years, its largest fall from a peak was 55.8%.
| Measure | Value |
|---|---|
| 1-year beta | 0.54 |
| Largest fall, 1 year | -55.3% |
| Largest fall, 3 years | -55.8% |
Valuation
Supernus Pharmaceuticals traded at 17.5x earnings at the end of 2025, against a 5-year median of 17.4x and a 10-year median of 54.9x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SUPN
What is SUPN's 1-year price change?
Supernus Pharmaceuticals's price fell 35.5% over the past 12 months. With dividends included, the 12-month total return was -17.4%.
What is SUPN's 5-year price change?
Supernus Pharmaceuticals's month-end price fell 76.3% over the 5 years through Oct 2026, a compound annual decline of 25.0%. These figures leave out dividends.
What is SUPN's 52-week high and low?
Supernus Pharmaceuticals's 52-week high is $33.22 and its 52-week low is $21.48. Its latest price of $29.04 on Nov 17, 2026 is 12.6% below the high.
What is SUPN's beta?
Supernus Pharmaceuticals's 1-year beta against the S&P 500 is 0.54, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 55.3%.
Is the SUPN chart free?
Yes. Advanced Charting for SUPN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SUPN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors